Emergent BioSolutions Inc. Revenue 2009–2025
Emergent BioSolutions Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Emergent BioSolutions Inc. revenue for the quarter ending March 31, 2026 was 156.1 M, a 29.75% decrease year-over-year.
- Emergent BioSolutions Inc. revenue for the twelve months ending March 31, 2026 was 750.3 M, a 32.97% decrease year-over-year.
- Emergent BioSolutions Inc. annual revenue for 2025 was 742.9 M, a 28.81% decrease from 2024.
- Emergent BioSolutions Inc. annual revenue for 2024 was 1.0 B, a 0.54% decrease from 2023.
- Emergent BioSolutions Inc. annual revenue for 2023 was 1.0 B, a 6.10% decrease from 2022.
- Emergent BioSolutions Inc. annual revenue for 2022 was 1.1 B.
Emergent BioSolutions Inc. (EBS) — Frequently Asked Questions
Emergent BioSolutions Inc. (EBS) is a publicly traded US company. It has a market capitalization of $467M. In fiscal 2025 it reported revenue of $743M and net income of $53M. Explore EBS's stock price, financial statements, earnings history, margins and key ratios below.
What is Emergent BioSolutions Inc.'s market cap?
Emergent BioSolutions Inc. (EBS) has a market capitalization of $467M.
What is the EBS stock price?
EBS trades at $8.24 (+3.65% on the day).
How much revenue does Emergent BioSolutions Inc. make?
Emergent BioSolutions Inc. reported revenue of $743M in fiscal 2025.
Is EBS profitable?
In fiscal 2025, Emergent BioSolutions Inc. reported net income of $53M.